Clinical Trial Update: Nonpolymer- and Polymer-Based Drug-Eluting Stents for Restenosis (ISAR-TEST-1) [Phase 4]

View source ↗

Summary

Phase 4 trial ISAR-TEST-1 evaluated nonpolymer- and polymer-based drug-eluting stents for restenosis in coronary artery disease. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Deutsches Herzzentrum Muenchen | Conditions: Coronary Disease | Phase 4 | Status: COMPLETED